pmc logo image
Logo of brmedjBMJ helping doctors make better decisionsSearchLatest content

Formats:

Br Med J. 1975 July 26; 3(5977): 195–197.
PMCID: PMC1674130
Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
P Roy, L Day, and E Sowton
Abstract
In 11 patients with severe angina pectoris a new beta-blocking drug, atenolol (Tenormin; I.C.I.66082), was found in a double-blind randomized trial to reduce significantly the frequency of anginal attacks (P less than 0-001) and the amount of trinitrin consumed (P less than 0-03) in comparison with practolol and placebo. There was no significant improvement in the patients' ability to exercise on the bicycle ergometer.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (573K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Gillam PM, Prichard BN. Propranolol in the therapy of angina pectoris. Am J Cardiol. 1966 Sep;18(3):366–369. [PubMed]
  • KEELAN P. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS. Br Med J. 1965 Apr 3;1(5439):897–898. [PubMed]
  • Wilson DF, Turner AS. Trasicor (39,089/Ba) in angina pectoris. A single-blind trial. N Z Med J. 1968 Mar;67(430):406–407. [PubMed]
  • Aström H, Vallin H. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris. Br Heart J. 1974 Dec;36(12):1194–1200. [PubMed]
  • MCNEILL RS. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. [PubMed]
  • Hamer J, Sowton E. Cardiac output after beta-adrenergic blockade in ischaemic heart disease. Br Heart J. 1965 Nov;27(6):892–895. [PubMed]